Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Biomed Opt ; 12(5): 054018, 2007.
Article in English | MEDLINE | ID: mdl-17994906

ABSTRACT

For bioluminescence imaging (BLI) of small animals, the most commonly used luciferase is Fluc from the firefly, but recently, green (CBGr99) and red (CBRed) click beetle luciferases became available. Because signal attenuation by tissues is lower for red light, red luciferases appear to be advantageous for BLI, but this has not been thoroughly tested. We compare different luciferases for BLI. For this purpose, cell transfectants are generated expressing comparable amounts of CBGr99, CBRed, or Fluc. This is achieved by coexpression of the luciferase with eGFP using the bicistronic 2A system, which results in stoichiometric coexpression of the respective proteins. In vitro, the CBGr99 transfectant exhibits the strongest total photon yield. For in vivo BLI, the transfectants are injected into mice at different locations. At a subcutaneous position, CBGr99 is clearly superior to the other luciferases. When the tumor cells are located in the peritoneum or lung, where more absorption by tissue occurs, CBGr99 and CBRed transfected cells emit a comparable number of red photons and are superior to Fluc, but CBGr99 reaches the maximum of the light emission faster than CBRed. Thus, although CBGr99 emits mainly green light, the high yield of total and red photons makes it an excellent candidate for BLI.


Subject(s)
Biomarkers, Tumor/metabolism , Luciferases/analysis , Luciferases/metabolism , Luminescent Measurements/methods , Melanoma/metabolism , Melanoma/pathology , Microscopy, Fluorescence/methods , Animals , Biomarkers, Tumor/analysis , Cell Line, Tumor , Coleoptera , Diptera , Luciferases/genetics , Mice , Mice, Inbred C57BL , Sensitivity and Specificity
2.
Life Sci ; 80(24-25): 2214-20, 2007 May 30.
Article in English | MEDLINE | ID: mdl-17363005

ABSTRACT

In recent years, the physiological role of non-neuronal acetylcholine (ACh) and its receptors (AChR) in epidermal physiology has been under intense investigation. However, little is known about the role of the non-neuronal cholinergic system in inflammatory skin diseases. We chose the clinically nicotine-dependent skin disease hidradenitis suppurativa (HS) as model to study the influence of long term nicotine ingestion on epidermal morphology and AChR expression. HS is a chronic inflammatory, disabling disease of unknown pathogenesis emerging from the pilosebaceous unit of the intertriginous areas. In order to correlate our findings to specific nicotine effects, we used the organotypical coculture system (OTC) and raised artificial epidermis in the presence of nicotine. After 12 days in culture control OTC showed a mature epithelium, while nicotine treated OTCs were significantly thicker. Using immunofluorescence analysis, nicotine treated OTCs produced significantly stronger immunoreactivity (IR) for the alpha3, M(3) and M(5) AChR antisera than control. In contrast, the alpha7 nAChR antiserum showed a slightly reduced IR in the granular layer and the alpha9 nAChR IR retracted to the lower suprabasal layers. In HS epidermis we found the strongest IR for all AChR around the follicular infundibulum while in the sinus epithelia it was only weak. In contrast to the nicotine treated OTC, the alpha7 nAChR IR in the hyperplastic HS epidermis was clearly extended to all living layers. Altogether we provide first hints for a causative role of the non-neuronal cholinergic system in the pathogenesis of HS by promoting infundibular epithelial hyperplasia and thus follicular plugging.


Subject(s)
Acetylcholine/metabolism , Epithelium/metabolism , Skin/metabolism , Acetylcholine/physiology , Epithelium/drug effects , Epithelium/pathology , Fluorescent Antibody Technique , Hidradenitis Suppurativa/metabolism , Hidradenitis Suppurativa/pathology , Hidradenitis Suppurativa/physiopathology , Humans , Microscopy, Fluorescence , Neurons/metabolism , Nicotine/pharmacology , Organ Culture Techniques/methods , Receptors, Nicotinic/metabolism , Receptors, Nicotinic/physiology , Skin/drug effects , Skin/pathology , Smoking/physiopathology , Tobacco Use Disorder/physiopathology
3.
J Invest Dermatol ; 126(11): 2458-72, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16810300

ABSTRACT

The aim of this study was to analyze the influence of cholinergic and anticholinergic drugs on epidermal physiology using organotypic cocultures (OTCs). Blocking of all acetylcholine receptors (AChRs) by combined treatment with mecamylamine and atropine or treatment with strychnine (blocking alpha9nAChR) for 7-14 days resulted in a complete inhibition of epidermal differentiation and proliferation. Blockage of nicotinic (n)AChR with mecamylamine led to a less pronounced delay in epidermal differentiation and proliferation than blockage of muscarinic (m)AChR with atropine, evidenced by reduced epithelial thickness and expression of terminal differentiation markers like cytokeratin 2e or filaggrin. In OTCs treated with atropine, mecamylamine, or strychnine, we could demonstrate intracellular lipid accumulation in the lower epidermal layers, indicating a severely disturbed epidermal barrier. In addition, we observed prominent acantholysis in the basal and lower suprabasal layers in mecamylamine-, atropine-, and strychnine-treated cultures, accompanied by a decreased expression of cell adhesion proteins. This globally reduced cell adhesion led to cell death via intrinsic activation of apoptosis. In contrast, stimulation of nAChR and mAChR with cholinergic drugs resulted in a significantly thickened epithelium, accompanied by an improved epithelial maturation. In summary, we show that epidermal AChR are crucially involved in the regulation of epidermal homeostasis.


Subject(s)
Acetylcholine/physiology , Epidermis/physiology , Receptors, Muscarinic/physiology , Receptors, Nicotinic/physiology , Apoptosis , Atropine/pharmacology , Biomarkers/analysis , Biomarkers/metabolism , Cell Adhesion , Cell Differentiation , Cell Proliferation , Cholinergic Agonists/pharmacology , Cholinergic Antagonists/pharmacology , Cytoskeletal Proteins/analysis , Cytoskeletal Proteins/metabolism , Desmosomal Cadherins/analysis , Desmosomal Cadherins/metabolism , Epidermal Cells , Epidermis/chemistry , Filaggrin Proteins , Homeostasis , Humans , Intermediate Filament Proteins/analysis , Keratin-2/analysis , Lipid Metabolism , Lipids/analysis , Mecamylamine/pharmacology , Organ Culture Techniques , Receptors, Muscarinic/drug effects , Receptors, Nicotinic/drug effects , Strychnine/pharmacology , Tight Junctions/chemistry , Tight Junctions/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL
...